Debut Plus

₹2,260.7

▼ -44.26 -1.92%

17 Jul 2026

NSE Listed

Beta Drugs Limited (BETA)

Volume: 18,575Avg Vol 1W: 56,009.2Avg Vol 1M: 34,80052W Range:₹990.1₹2,424.3
NSE BSE www.betadrugslimited.com
Key Ratios
Checked 18h ago
Market Cap₹2,337 Cr
Current Price₹2,260.7
Previous Close₹2,304.96
High / Low (52w)₹2,424.3 / ₹990.1
Volume18,575
Avg Vol (1W)56,009.2
Avg Vol (1M)34,800
Stock P/E258.12
Book Value₹241.39
Dividend Yield0%
ROE17%
ROA8.4%
Revenue (TTM)₹369 Cr
Revenue Growth22.5%
Profit Margin10.8%
Total Debt₹127 Cr
Shares Outstanding1 Cr
Face Value₹10
EPS (TTM)₹8.93
P/B9.55
Debt / Equity0.6
50 DMA₹1,806.51
200 DMA₹1,558.75
Day change-1.92%
Price Chart
₹2,260.7▲ 34.81% · 1Y
₹2367₹10302.2L
2025-07-16
2026-07-15

20-day avg volume: 35K shares

Pros
  • Healthy return on equity of 17.0%.
  • Company is almost debt-free.
Cons
  • Revenue fell 23% YoY.
  • Stock trades at a high P/E of 258.
Quarterly Results
MetricDec 2024Mar 2025Sept 2025Dec 2025Mar 2026
Revenue₹88 Cr₹94 Cr₹103 Cr₹87 Cr₹94 Cr
EBITDA₹16 Cr₹18 Cr₹20 Cr₹15 Cr₹16 Cr
Net Profit₹9 Cr₹9 Cr₹12 Cr₹9 Cr₹9 Cr
EPS—————
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹51 Cr₹66 Cr₹91 Cr₹117 Cr₹185 Cr₹228 Cr₹297 Cr₹369 Cr
EBITDA₹8 Cr₹9 Cr₹15 Cr₹18 Cr₹36 Cr₹43 Cr₹52 Cr₹69 Cr
Net Profit₹7 Cr₹8 Cr₹9 Cr₹12 Cr₹25 Cr₹31 Cr₹36 Cr₹42 Cr
EPS7.829.39.7912.225.8231.9537.942.02
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹50 Cr₹83 Cr₹107 Cr₹118 Cr₹158 Cr₹198 Cr₹254 Cr₹436 Cr
Total Liabilities₹17 Cr₹42 Cr₹50 Cr₹49 Cr₹66 Cr₹76 Cr₹97 Cr₹239 Cr
Equity₹33 Cr₹41 Cr₹57 Cr₹69 Cr₹92 Cr₹123 Cr₹157 Cr₹197 Cr
Total Debt————————
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹17 Cr₹0 Cr₹8 Cr₹19 Cr₹30 Cr₹23 Cr₹31 Cr₹36 Cr
Investing₹-11 Cr₹-21 Cr₹-15 Cr₹-6 Cr₹-22 Cr₹-19 Cr₹-14 Cr₹-36 Cr
Financing₹5 Cr₹12 Cr₹9 Cr₹-8 Cr₹-1 Cr₹-2 Cr₹-7 Cr₹118 Cr
Free Cash Flow₹17 Cr₹0 Cr₹8 Cr₹19 Cr₹30 Cr₹23 Cr₹31 Cr₹36 Cr
Shareholding
Promoter 59.1% Institutions 8.97% Public 31.93%
Efficiency & Working Capital
ROCE24.5%
Interest Coverage9.2
Dividend Payout—
Debtor Days103 d
Inventory Days60 d
Payable Days72 d
Cash Conversion Cycle92 d
Working Capital Days164 d
Shareholding Details

As of 2026-05-31

Promoter59.1%
FII3%
DII6%
Institutions9%
Public31.9%
Promoter Pledge0%
No. of Shareholders5,027
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2024Nov 2024Nov 2024Dec 2024Mar 2025Jun 2025Sept 2025Nov 2025Nov 2025Dec 2025Mar 2026May 2026
Promoters66.7%66.7%66.7%66.7%66.7%66.7%66.7%66.7%66.7%64.9%66.7%59.1%
FIIs1.2%1.2%1.2%1.2%0.9%0.9%0.9%0.9%0.9%1.1%0.9%3%
DIIs0%0.2%0%0%0%0%0%0.3%0%1.9%0.3%6%
Public32.1%31.9%32.1%32.1%32.4%32.4%32.4%32.1%32.4%32.1%32.1%31.9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders2,5672,7932,7932,8823,0543,1393,1843,0033,0033,6943,1845,027
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Neeraj BatraShareholding of Promoter and Promoter Group58.4%64,73,631
Suryavanshi Commotrade Private LimitedPublic Shareholding6.1%6,80,026
Ashish KacholiaPublic Shareholding5.2%5,79,097
Healthquad Trust IiPublic Shareholding4.1%4,53,623
Inti Capital Vcc - Inti Capital IPublic Shareholding1.9%2,11,691
Airavat Capital Trust - Airavat Capital Trust IiPublic Shareholding1.6%1,77,171
Bsas Infotech LimitedPublic Shareholding1.2%1,32,762
Anjali Ajit DevalPublic Shareholding1.1%1,25,596
Rahul BatraShareholding of Promoter and Promoter Group0.4%41,632
Varun BatraShareholding of Promoter and Promoter Group0.3%34,891
Aditi BatraShareholding of Promoter and Promoter Group0%619
Heena BatraShareholding of Promoter and Promoter Group0%619
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Neeraj Batra00%2026-05-25
Rahul Batra00%2026-05-25
Varun Batra00%2026-05-25
Aditi Batra00%2026-05-25
Heena Batra00%2026-05-25
Healthquad Trust Ii00%2026-05-25
Airavat Capital Trust - Airavat Capital Trust Ii00%2026-05-25
Inti Capital Vcc - Inti Capital I00%2026-05-25
Ashish Kacholia00%2026-05-25
Anjali Ajit Deval00%2026-05-25
Suryavanshi Commotrade Private Limited00%2026-05-25
Bsas Infotech Limited00%2026-05-25
Board of Directors
NameDesignationYear
Rahul BatraChairman & Managing Director2025
Varun BatraJoint Managing Director2025
Balwant SinghWhole-time Director2025
Ashutosh ShuklaWhole-time Director2025
Ajay MahipalNon Executive Director2025
Rohit PartiIndependent Director2025
Manmohan KhannaIndependent Director2025
Sanjay SehgalIndependent Director2025
Lalit Kumar WattsIndependent Director2025
Monica JainIndependent Director2025
Rajni BrarCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Manufacturing of Oncology Medicines₹0 Cr—
Segments — Geography
RegionRevenueShare
Domestic Sales₹156 Cr71%
Export Sales₹64 Cr29%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10111010
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202526004031
2025100001
202524004029
Company Information
Incorporated2005
ChairmanRahul Batra
AuditorKhurana Sharma & Co
Investor Email[email protected]
🌐 www.betadrugslimited.com ↗

📍 Village Nandpur, Baddi, Himachal Pradesh, 174101

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Belrise Industries Ltd.BEMLBengal & Assam Co. Ltd.Bhansali Eng. Polymers Ltd.Berger Paints (I) Ltd.Best Agrolife LimitedBEW Engineering LimitedBF InvestmentBF Utilities LimitedBharatiya Global Info Ltd.BGR Energy Systems Ltd.Bhadora Industries Ltd.All “B” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search